Overview

KN046 in Patients With Advanced Non-small Cell Lung Cancer

Status:
Recruiting
Trial end date:
2022-03-01
Target enrollment:
Participant gender:
Summary
This is a phase II, open label, multicenter study in subjects with advanced non-small cell lung cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Jiangsu Alphamab Biopharmaceuticals Co., Ltd